EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TcSR62, an RNA-binding protein, as a new potential target for anti-trypanocidal agents

Analía G Níttolo, Agustina M Chidichimo, Ana L Benacerraf, Timothy Cardozo, M Clara Corso, Valeria Tekiel, Javier G De Gaudenzi, Gabriela Vanesa Levy

Frontiers in Microbiology · 12.03.2025 · 16

DOI: 10.3389/fmicb.2025.1539778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.03.2025. Verfasst von Analía G Níttolo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC), La Plata, Argentina. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trypanosomatids are parasites of health importance that cause neglected diseases in humans and animals. Chagas’ disease, caused by Trypanosoma cruzi , affects 6–7 millions of people worldwide, mostly in Latin America, most of whom do not have access to diagnosis or treatment. Currently, there are no available vaccines, and the antiparasitic drugs used for treatment are often toxic and ineffective for the chronic stage of infection. Therefore, exploration of new therapeutic targets is necessary and highlights the importance of identifying new therapeutic options for the treatment of this disease. Trypanosomatid genes are organized and expressed in a species-specific fashion and many of their regulatory factors remain to be explored, so proteins involved in the regulation of gene expression are interesting candidates as drug targets. Previously, we demonstrated that the TbRRM1 protein from T. brucei is an essential nuclear factor involved in Pol-II transcriptional regulation. TcSR62 is a TbRRM1 orthologous protein in T. cruzi , but little is known about its function. In this study, we used molecular modeling of the RNA-binding domains of the TcSR62 protein and computational molecular docking to identify TcSR62-specific drug candidates. We identified sorafenib tosylate (ST) as a compound with trypanocidal activity. Sorafenib tosylate showed promising half-maximal inhibitory concentration (IC50) for all parasite stages in vitro . Furthermore, overexpression of TcSR62 protein led to ST-resistant parasites, suggesting that the trypanocidal effect might be due to the inhibition of TcSR62 function. These results demonstrate that ST could be repurposed as a novel drug to treat Chagas’ disease.

Schlagwörter

Stichwörter der Autor:innen

Chagas diseaseIC50Trypanosoma cruzidrug repurposingmolecular modelingresazurinsorafenib tosylatetreatment

Autor:innen und Institutionen

  • Comisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC), La Plata, Argentina.
  • Departamento de Ciencias de la Salud, Universidad Nacional de La Matanza, San Justo, Argentina.
  • Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín (UNSAM) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), San Martin, Argentina.
  • Escuela de Bio y Nanotecnologías (EByN), Universidad Nacional de San Martín, San Martin, Argentina.
  • NYU Langone Health, New York University School of Medicine, New York, NY, United States.

Zitieren

APA

Níttolo, A. G., Chidichimo, A. M., Benacerraf, A. L., Cardozo, T., Corso, M. C., Tekiel, V., De Gaudenzi, J. G., & Levy, G. V. (2025). TcSR62, an RNA-binding protein, as a new potential target for anti-trypanocidal agents. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1539778

Vancouver

Níttolo AG, Chidichimo AM, Benacerraf AL, Cardozo T, Corso MC, Tekiel V, et al. TcSR62, an RNA-binding protein, as a new potential target for anti-trypanocidal agents. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1539778

BibTeX
@article{Nttolo2025,
  author = {Níttolo, Analía G and Chidichimo, Agustina M and Benacerraf, Ana L and Cardozo, Timothy and Corso, M Clara and Tekiel, Valeria and De Gaudenzi, Javier G and Levy, Gabriela Vanesa},
  title = {TcSR62, an RNA-binding protein, as a new potential target for anti-trypanocidal agents},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1539778}
}
Kostenlos starten →